HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus.

Abstract
Several instruments have been developed to assess disease activity in systemic lupus erythematosus. Any study of a new laboratory measure, any therapeutic trial, and any study of outcome and prognosis should include one of these validated measures of disease activity. The treatment of lupus is far from ideal. A controlled trial of plasmapheresis showed no benefit over standard regimens in lupus nephritis. A long course of pulse cyclophosphamide was shown to be better than pulse methylprednisolone or a short course of intravenous pulse cyclophosphamide. Despite the lack of ideal therapy, the prognosis of lupus, including 15-year survival rates, has improved over the past 4 decades. Specific organ damage continues to be an issue. Infection and vascular disease have emerged as important factors. With improved survival, other outcome measures, including specific organ function and health status, must be considered.
AuthorsD D Gladman
JournalCurrent opinion in rheumatology (Curr Opin Rheumatol) Vol. 5 Issue 5 Pg. 587-95 (Sep 1993) ISSN: 1040-8711 [Print] United States
PMID8398609 (Publication Type: Journal Article, Review)
Chemical References
  • Glucocorticoids
  • Cyclophosphamide
  • Methylprednisolone
Topics
  • Cause of Death
  • Cyclophosphamide (therapeutic use)
  • Glucocorticoids (therapeutic use)
  • Health Status Indicators
  • Humans
  • Lupus Erythematosus, Systemic (mortality, physiopathology, therapy)
  • Methylprednisolone (therapeutic use)
  • Outcome Assessment, Health Care
  • Plasmapheresis
  • Prognosis
  • Severity of Illness Index
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: